- Tytuł:
- Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms.
- Autorzy:
- Temat:
-
MITOXANTRONE
CLINICAL trials
CANCER chemotherapy
MONOCLONAL antibodies
ANTINEOPLASTIC agents
TREATMENT effectiveness
CANCER patients
PROGRESSION-free survival
PHARMACODYNAMICS - Źródło:
- Cancers; Jun2022, Vol. 14 Issue 12, p2934-N.PAG, 15p
Czasopismo naukowe